Seiji Naganuma
- Molecular Biology
- Oncology top 10%
- Cancer Research top 10%
- Surgery
- Hepatology top 5%
- Co-authors
- Hiroshi ItohMutsuo FurihataMitsuteru NatsuizakaKeisuke TaniuchiAndres J. Klein–SzantoToshiji SaibaraHiroshi NakagawaShinya Ohashi
- Topics
- Liver physiology and pathology (7 papers)Cancer Cells and Metastasis (5 papers)Pancreatic and Hepatic Oncology Research (5 papers)
- Cited by
- Cancer ResearchHepatologyOncology
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Seiji Naganuma
38 papers receiving 778 citations
Peers
Comparison fields: 5 of 71
- Molecular Biology 429
- Oncology 242
- Cancer Research 236
- Surgery 193
- Hepatology 117
Countries citing papers authored by Seiji Naganuma
This map shows the geographic impact of Seiji Naganuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seiji Naganuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seiji Naganuma more than expected).
Fields of papers citing papers by Seiji Naganuma
This network shows the impact of papers produced by Seiji Naganuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seiji Naganuma. The network helps show where Seiji Naganuma may publish in the future.
Co-authorship network of co-authors of Seiji Naganuma
This figure shows the co-authorship network connecting the top 25 collaborators of Seiji Naganuma. A scholar is included among the top collaborators of Seiji Naganuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seiji Naganuma. Seiji Naganuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 9 | |
| 3 | 8 | |
| 4 | 4 | |
| 5 | 7 | |
| 6 | Elevated Expression of SCGB1D2 Predicts Unfavorable Prognosis in Patients with Pancreatic Ductal Adenocarcinoma | 1 |
| 7 | 15 | |
| 8 | 21 | |
| 9 | 57 | |
| 10 | 52 | |
| 11 | 89 | |
| 12 | 22 | |
| 13 | 36 | |
| 14 | 2 | |
| 15 | 5 | |
| 16 | 7 | |
| 17 | 5 | |
| 18 | 52 | |
| 19 | 62 | |
| 20 | 8 |
About Seiji Naganuma
Seiji Naganuma is a scholar working on Hepatology, Oncology and Cancer Research, having authored 38 papers that have together received 795 indexed citations. Recurring topics across this work include Liver physiology and pathology (7 papers), Cancer Cells and Metastasis (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Cancer Research (236 citations), Hepatology (117 citations) and Oncology (242 citations). Seiji Naganuma has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Hiroshi Itoh, Mutsuo Furihata, Mitsuteru Natsuizaka, Keisuke Taniuchi, Andres J. Klein–Szanto, Toshiji Saibara, Hiroshi Nakagawa, Shinya Ohashi, J. Alan Diehl and Phyllis A. Gimotty. Their work appears in journals such as Gastroenterology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.